Lantern Pharma Inc
Price
FilingsNewest: 8-K, Listing noticeOct 1 →Insiders2 insiders bought $200,001 in 2 open-market buys. No sales.→HoldersEmpery 6.6%CM 3.9%Vanguard 3.3%→Financing →PeersClosest companies: SNTI, CALC, FBLG→
From the filings
Figures
- Net income
- −$18.7Mlast 12 months
- Operating cash flow
- −$15.1Mlast 12 months
- Cash and equivalents
- $6.7Mat the last balance sheet
- Shares outstanding
- 12.8M shareson issue